Liposomal daunorubicin in advanced Kaposi's sarcoma: A phase II study
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 5 (6) , 367-371
- https://doi.org/10.1016/s0936-6555(05)80088-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trialThe American Journal of Medicine, 1991
- A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposiʼs sarcoma and AIDSAIDS, 1991
- Treatment of Advanced Kaposiʼs Sarcoma Using a Combination of Bleomycin and VincristineAmerican Journal of Clinical Oncology, 1990
- Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudineAnnals of Oncology, 1990
- Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapyCancer, 1990
- Oral kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastineCancer, 1989
- INTRALESIONAL VINBLASTINE FOR ORAL KAPOSI SARCOMA IN HIV INFECTIONThe Lancet, 1989
- Aids-associated kaposiʼs sarcomaAIDS, 1988
- Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron® A)Cancer, 1987
- Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.Journal of Clinical Oncology, 1984